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N, N- diethyl- m- toluamide (DEET) stimulate cellular processes leading 
to angiogenesis via the activation of muscarinic receptors
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Marchais (2), Bruno Lapied (2), Ramaroson Andriantsitohaina (1), 
Sébastien Faure (1)
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Insect repellents containing DEET are highly effective through an inhibi-
tion of acetylcholinesterase (AChE) activity and these pesticides have been 
reported to play a role in tumor development. Different mechanisms can lead 
to stimulate angiogenesis, such as the inhibition of AChE activity. The present 
study was designed to test the potential effect of DEET on different processes 
leading to angiogenesis on human endothelial cells (HUVECs) including pro-
liferation, adhesion and migration through an involvement of cholinergic 
receptors. DEET was incubated for 24h on HUVECs at concentrations similar 
to that found in plasma of exposed individuals (10- 5M) or in the environ-
ment (10- 8M). VEGF(20 ng/mL) was used as a positive control. Proliferation 
was analyzed by using CyQUANT Cell Proliferation Assay Kit. Evaluation of 
adhesion was performed using crystal violet staining. Cell migration was eva-
luated using Transwell migration kit. Analysis of both superoxide anion (O2- ) 
and nitric oxide (NO) productions were performed using electronic parama-
gnetic resonance technique. Quantitation of AchE activity was performed by 
Ellman colorimetric assay. The two concentrations of DEET increased cell 
proliferation. Moreover, it potentiated cell migration that was associated with 
enhanced MMP2 activity and endothelial cell adhesion through an enhance-
ment of FAK phosphorylation and stress ¿ bers. Although it did not modify 
O2- production, DEET increased NO production through an increase of 
peNOS- Ser/peNOS- Thr ratio. All of these cellular processes were partially 
prevented by methoctramide and pFHHSiD, M2 and M3 antagonists, respec-
tively and DEET inhibited endothelial AChE activity. Altogether, these data 
highlight that DEET modulates cellular angiogenic processes through an acti-
vation of muscarinic receptors. In addition to their toxic effects on nervous 
system, this study underscores that DEET may affect the generation of vas-
cular network that could potentiate proliferative diseases.
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Targeting VEGFR1 on endothelial progenitors modulates their differ-
entiation potential
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Delphine Borgel (3), Ivan Bièche (4), Michel Vidal (2), Pascale Gaussem (1), 
David Smadja (1)
(1) INSERM UMR- S 765, Paris, France - (2) CNRS UMR 8638, Paris, 
France - (3) AP- HP, Hôpital Ambroise Paré, Hématologie biologique, 
Boulogne- Billancourt, France - (4) INSERM UMR 745, Paris, France
Objectives: We studied whether plasma levels of angiogenic factors and 
endothelial markers in coronary artery disease patients or undergoing cardiac 
surgery are modi¿ ed, and whether those factors modulate endothelial progeni-
tor’s angiogenic potential.
Methods and Results: 143 patients plasmas from two different studies 
were analyzed (30 coronary artery disease patients, 30 patients with stable 
angina, coupled with 30 age and sex- matched controls; 53 patients underwent 
cardiac surgery). Among factors screened, only placental growth factor (PlGF) 
was found signi¿ cantly increased in these pathological populations. PlGF- 1 
and - 2 were then tested on human endothelial colony forming cells (ECFCs). 
We found that PlGF- 1 and - 2 induce VEGFR1 phosphorylation and potentiate 
ECFCs tubologenesis in vitro. ECFCs VEGFR1 was further inhibited using 
a speci¿ c small interfering RNA (siRNA) and the chemical compound 4321. 
We then observed that the VEGFR1- siRNA and the 4321 compound decrease 
ECFCs tubologenesis potential in vitro. Finally we tested the 4321 compound 
in the preclinical Matrigel®- plug model with C57Bl/6J mice, and found that 
4321 inhibited the plug vascularization, attested by the haemoglobin content 
and the VE- Cadherin expression level.
Conclusion: PlGF plasma levels were found increased in cardiovascular 
patients. Disrupting PlGF/VEGFR1 pathway could modulate ECFCs induced 
tubulogenesis, the cell type responsible for newly formed vessels in vivo.
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Frizzled 7 is required for post natal angiogenesis
Claire Peghaire [Orateur], Raj Sewduth, Thierry Couf¿ nhal, Cécile Duplaa, 
Pascale Dufourcq
INSERM 1034, Pessac, France
Vessel formation requires a precise orchestration of a serie of morphometric 
and molecular events controlled by a multitude of angiogenic factors. Growing 
evidence has shown that Wnt/Fzd proteins are expressed in vascular cells and 
are directly involved in blood vessel development by regulating endothelial 
cells proliferation, polarity and vascular branching morphogenesis. In this 
study, we analyzed the consequences of fzd7 receptor deletion on postnatal 
vessel formation in mice retina by developing a Cre- Lox strategy. Tie2Cre+/
fzd7f/Wt mice were crossed with fzd7f/f mice to generate Tie2Cre+/fzd7f/f (fzd7 
ECKO) mice where fzd7 gene is deleted speci¿ cally in endothelial cells. These 
mice are viable and have been used and compared with WT mice.
The retinas of pups sacri¿ ced 7 days after birth were immunostained (CD31, 
NG2 and SMA) to study the kinetics of vascular plexus formation. We observed 
that fzd7ECKO mice had a delay in vascular network formation compared to WT 
(- 18% of vascular radial extension, p<0.01). In the fzd7ECKO retinas, vascular 
density and the branching of this network were signi¿ cantly increased. Confocal 
microscopy analysis of tip- cell at the migration front showed a strong impair-
ment of tip- cell phenotype in the fzd7ECKO retina vs. WT. We observed a signi-
¿ cant increase in tip cell number (+40%, p<0.05) and ¿ lopodia number per tip 
cell (+48.5%, p<0.05). These ¿ lopodia were disorganized and misguided. 
Due to the impairment of tip cell phenotype in fzd7ECKO mice, we ana-
lyzed in vivo and in vitro, the expression of Notch partners by quantitative RT- 
PCR. In vivo, fzd7 deletion induced a decrease in Notch ligands (Dll4, Jag1), 
Notch receptors (Notch1, Notch4) and Hey2 expression. Moreover, in vitro 
siRNA strategy against fzd7 on murine EC con¿ rmed these results. This study 
shows that fzd7 is required for the formation of vascular network and that fzd7 
appears to regulate the phenotype of the tip cells.
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ANGPTL4- αVβ3 integrin interaction counteracts VEGFR2 signaling 
and hypoxia- induced vascular leakage
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We previously showed that ANGPTL4- mediated vasculoprotection is crucial 
for secondary cardioprotection during AMI and might constitute a relevant 
target for therapeutic intervention as it contributes to decrease hemorrhage, 
edema, inÀ ammation « no- reÀ ow » phenomenom and infarct size in ischemia- 
reperfusion models. The aim of this study is to decipher the mechanisms through 
which ANGPTL4 preserves vascular integrity during ischemic diseases.
We show that vascular leakage is increased in angptl4- de¿ cient mice 
during choroidal neovascularization. Recombinant human ANGPTL4 inhibits 
hypoxia–induced vascular permeability and increases adherens and tight junc-
tions integrity. Using the Surface Plasmon Resonance (SPR) binding technique 
and a vascular permeability assay combined with a blocking antibody strategy, 
we show that this inhibition is mediated through ANGPTL4 binding to inte-
grin αVβ3. Finally, biochemical analyses reveal that ANGPTL4 modulates Src 
recruitment and activation at integrin αVβ3, VEGFR2 and VE- Cadherin com-
plexes and decreases VEGF signaling.
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ANGPTL4 acts through binding to αVβ3 integrin in order to counteract 
vascular permeability. Mechanistically, ANGPTL4- αVβ3 integrin interaction 
increases Src recruitment to αVβ3 complexes, thereby leading to a diminished 
Src signaling at VEFGR2. This translates to decreased breakdown of the 
VEGFR2/VE- cadherin complex and an increased stability of tight and adhe-
rens junctions in endothelial cells.
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Gli3 promotes ischemia- induced angiogenesis at least in part by regu-
lating post- natal myogenesis
Soizic Vandierdonck [Orateur], Candice Chapouly, Qinyu Yao, Cécile 
Allières, Annabel Reynaud, Béatrice Vinassa, Isabelle Belloc, Claude 
Desgranges, Alain- Pierre Gadeau, Marie- Ange Renault
Inserm, Unité 1034, Pessac, France
Background: Skeletal muscle regeneration occurs after many traumas and 
diseases including congenital myopathies, ischemic diseases and sports related 
injuries. Understanding mechanism underlying skeletal muscle repair is then 
of great interest. The embryonic Hedgehog (Hh) signaling was shown to be 
still active in adults and to regulate myogenesis and angiogenesis, two crucial 
processes for muscle regeneration. This study further characterizes cellular 
and molecular mechanisms coordinating angiogenesis and myogenesis and the 
role of the Hh transcription factor Gli3. 
Results: Because we recently found that Gli3 is essential for ischemic 
muscle repair, we used mice in which Gli3 has been speci¿ cally disrupted in 
ECs (Tie2- Cre; Gli3Flox/Flox) or in skeletal myocytes (HSA- CreERT2; Gli3Flox/
Flox) and found that Gli3 KO in ECs does not signi¿ cantly impairs hind limb 
ischemia- induced muscle repair while Gli3 KO in myocytes severely delays 
ischemia- induced myogenesis. Moreover, this study shows that angiogenesis 
is also signi¿ cantly impaired in HSA- CreERT2; Gli3Flox/Flox mice demonstra-
ting that impaired myogenesis, indirectly affects ischemia- induced angioge-
nesis. The role of Gli3 in myocytes was then further investigated in vitro. We 
found that Gli3 promotes myoblast differentiation through Myf5 regulation; 
moreover Gli3 expression level regulates several proangiogenic factors inclu-
ding Angiopoietin1 and Thymidine phosphorylase in myoblasts which indi-
rectly regulate EC proliferation. Finally this study shows for the ¿ rst time that 
Hh signaling and more particularly Gli3 mRNA expression can be regulated 
by myogenic growth factors including IGF- 1. 
Conclusion: The study shows that ischemia- induced angiogenesis is tightly 
regulated by myogenesis at least in part through Gli3 regulation in myocytes 
and suggest that myogenic therapy can be considered to promote ischemia- 
induced angiogenesis and muscle repair.
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Palmitic acid promotes pro- oxidant adaptor protein p66Shc expression 
and affects vascularization factors in pro- angiogenic cells
Julie Favre [Orateur], Cansu Yildirim, Juan- Jesus Garcia- Vallejo, Ruud 
Fontijn, Tineke Van Der Pouw- Kraan, Anton Horrevoets
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Type- 2 diabetes is associated with impaired neovascularisation, which 
involves dysfunction of circulating pro- angiogenic mononuclear cells (CAC). 
Elevated plasma free fatty acid (FFA) levels such as palmitic acid (PA), and 
oxidative stress may directly affect CAC numbers and function. Interestingly, 
a recent study pointed out the lifespan regulator p66Shc, a pro- oxidant adaptor 
protein as a modulator of KLF2 (Krüppel- like factor 2), a bene¿ cial actor of 
CAC and endothelial function. We thus aimed to follow the molecular impact 
of high levels of FFA in CACs in vitro. 
CACs were differentiated from peripheral blood mononuclear cells in an 
endothelial growth medium. At day 6, adherent cells pretreated or not with 
30M resveratrol (which promotes endothelial KLF2) for 3 days, were sub-
mitted to a 24h treatment with PA (200 or 400 M) or vehicle. Q- PCR ana-
lysis was performed. Cytoplasmic reactive oxygen species production was 
measured with the oxidative sensitive À uorescent probe CM- DCF. Protein 
levels of Tie2 and VEGFR2 were measured by FACS and Imagestream 
cytometer.
We observed that while KLF2 expression tended to decrease, PA 
markedly and dose- dependently enhanced p66Shc mRNA expression 
(6 fold). PA did not markedly affect CAC number but a rise in oxida-
tive stress was evidenced by higher number of CM- DCF positive cells. 
Resveratrol pretreatment reversed PA- induced oxidative stress and tended 
to normalize gene expression levels. Interestingly, PA- induced p66shc 
increase correlated with a large rise in mRNA expression of VEGF- A (10 
fold). Conversely, surface membrane expression of VEGFR2 and Tie2 
decreased after PA treatment. 
We show for the ¿ rst time that high levels of FFA can directly impair 
CAC function, possibly via an increase in p66Shc- induced oxidative stress 
leading to a deregulated VEGF- A over- expression. The associated decrease in 
major receptors involved in neovascularization, such as VEGFR2 and Tie2, 
highlights the potent deleterious action of PA in this process.
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Role of lysyl oxidase like- 2 in tumor angiogenesis
Virginie Lelarge [Orateur], Cathy Pichol- Thievend, Sébastien Gauvrit, 
Alain Barret, Laurent Muller, Catherine Monnot, Stéphane Germain
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Hypoxia- driven remodeling of the microenvironment, consisting in extra-
cellular matrix (ECM) and various cell types is a regulated process involved 
in angiogenesis and tumor progression. Lysyl oxidase like- 2 (LOXL2) is upre-
gulated in many cancers in both tumor and stromal cells and involved in ECM 
crosslinking. We demonstrated that : 1/LOXL2 secretion is upregulated by 
hypoxia in endothelial cells and accumulates in the ECM ; 2/LOXL2 regulates 
sprouting angiogenesis and type IV collagen assembly in the endothelial base-
ment membrane during developmental vascularisation (Bignon, Blood 2011). 
Inhibition of extracellular LOXL2 impedes the development of pathologic 
microenvironment and thereby controls cancer progression (Barry- Hamilton, 
Nat. Med. 2010). We therefore aimed to investigate the role of LOXL2 in 
tumor angiogenesis.
As metastatic progression is dependent on the tumor microenvironment, we 
carried out the analysis of loxl2 mRNA in a collection of human metastatic 
tissues. Our data evidenced a strong expression of loxl2 mRNA in adrenal 
metastasis from renal clear cell carcinoma.
In parallel, we assessed the functional involvement of LOXL2 in regula-
ting angiogenesis using:
1/ An in vitro 3D angiogenesis model of HUVEC spheroids included in 
a mixed Matrigel/¿ brin gel. We show that the length of endothelial tubes is 
increased in comparison to control conditions when recombinant LOXL2 is 
added into the gel.
2/An in vivo angiogenesis model in mice, based on subcutaneous injections 
of Matrigel/¿ brin that contains or not LOXL2. Our earliest results show an 
increased vascularisation of the LOXL2- containing Matrigel plugs compared 
to control, as evidenced by quantifying the hemoglobin content at Day 7.
Altogether, these results support that LOXL2 secreted in tumor microenvi-
ronment is involved in regulating angiogenesis. Further studies are ongoing to 
determine the synergy between LOXL2- induced angiogenesis, remodeling of 
the microenvironment and tumor progression.
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